V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260008269 | 260005575 | null | 55.7 | Palliative (P) | 2014-11-27 | 2015-07-23 | Capecitabine + Oxaliplatin 21day | N | N | 260027550 | PACIFICO TRIAL |
| 260008270 | 260005575 | 1.62 | 66.3 | Curative (C) | 2016-09-08 | 2016-09-13 | Rituximab | N | N | 260027550 | RITUXIMAB |
| 260008271 | 260005576 | 1.79 | null | Curative (C) | 2016-10-12 | 2016-10-31 | Rituximab | N | N | 260027553 | RITUXIMAB |
| 260008272 | 260005576 | 1.79 | null | Curative (C) | 2015-10-28 | 2015-10-29 | CAPECITABINE + OXALIPLATIN | Y | N | 260027553 | RITUXIMAB |
| 260008273 | 260005576 | null | 61.6 | null | null | 2014-08-08 | Rituximab | null | null | 260027553 | VINCRISTINE |
| 260008274 | 260005576 | 1.7 | null | Curative (C) | 2015-05-06 | 2015-06-02 | R-EPOCH | 02 | N | 260027553 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260008275 | 260005577 | 1.79 | 48 | Palliative (P) | 2016-10-18 | 2016-11-08 | Rituximab (Maintenance) | 01 | null | 260027570 | PACIFICO TRIAL |
| 260008276 | 260005577 | 1.67 | 67.3 | Palliative (P) | 2013-05-31 | 2013-06-25 | Carboplatin + Pemetrexed | Y | N | 260027570 | TRIAL |
| 260008277 | 260005578 | 1.65 | 70 | Palliative (P) | 2014-10-03 | 2014-10-29 | R Chlorambucil | N | N | 260027573 | RITUXIMAB |
| 260008278 | 260005578 | 1.83 | 81.7 | Disease modification (D) | 2013-02-17 | 2013-02-19 | Trial Unspecified | 02 | null | 260027573 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008279 | 260005579 | 1.73 | 53.9 | null | null | 2016-05-02 | BENDAMUSTINE | N | null | 260027576 | CHLORAMBUCIL |
| 260008280 | 260005579 | null | 93 | Curative (C) | 2017-02-24 | 2017-03-12 | ABVD | N | N | 260027576 | FCR |
| 260008281 | 260005580 | 1.69 | 64.7 | Palliative (P) | 2016-08-11 | 2016-08-11 | Trial Unspecified | 02 | null | 260027580 | RITUXIMAB |
| 260008282 | 260005581 | 1.6 | 62.3 | Disease modification (D) | 2018-01-10 | 2018-01-25 | Rituximab | N | N | 260027584 | RITUXIMAB |
| 260008283 | 260011865 | 1.86 | 96.2 | Curative (C) | 2013-06-26 | 2013-06-27 | CHLORAMBUCIL + RITUXIMAB | N | N | 260027585 | RITUXIMAB |
| 260008284 | 260005582 | 1.84 | 49.6 | Curative (C) | null | 2018-06-26 | Rituximab | null | null | 260027586 | RITUXIMAB |
| 260008285 | 260005583 | 1.84 | 73 | null | 2015-10-13 | 2015-10-14 | Cisplatin + Vinorelbine (PO) | 02 | null | 260027590 | CISPLATIN + ETOPOSIDE |
| 260008286 | 260005584 | null | null | Curative (C) | 2014-12-01 | 2014-12-07 | Doxorubicin + Olaratumab | N | N | 260027592 | RITUXIMAB |
| 260008287 | 260005585 | 1.83 | 72 | Curative (C) | null | 2017-02-06 | Rituximab | N | N | 260027596 | RITUXIMAB |
| 260008288 | 260005585 | 1.65 | 63 | Disease modification (D) | 2016-04-13 | 2016-04-14 | BENDAMUSTINE | 02 | N | 260027596 | RITUXIMAB |
| 260008289 | 260005585 | 1.89 | 97 | Disease modification (D) | 2014-05-01 | 2014-05-01 | ACE (germ cell) | N | N | 260027596 | CVD |
| 260008290 | 260005585 | 1.65 | 86.15 | Palliative (P) | 2017-05-06 | 2017-05-07 | PACIFICO TRIAL | N | N | 260027596 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008291 | 260005585 | -1 | 122.7 | Curative (C) | 2015-06-03 | 2015-07-08 | Rituximab (Maintenance) | null | null | 260027596 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008292 | 260018884 | 1.84 | 77.4 | null | 2016-10-24 | 2016-10-24 | Rituximab | 02 | null | 260027604 | CARBOPLATIN + ETOPOSIDE |
| 260008293 | 260005586 | 1.8 | 82.1 | Curative (C) | 2015-07-12 | 2015-07-16 | Cisplatin + Etoposide (3 day) | 02 | N | 260027610 | BLEOMYCIN + CISPLATIN + VINBLASTINE |
| 260008294 | 260005586 | 1.88 | 76.3 | Curative (C) | 2014-03-01 | 2014-03-01 | Rituximab (Maintenance) | 02 | N | 260027610 | BENDAMUSTINE |
| 260008295 | 260005587 | 1.67 | 100 | null | 2016-02-09 | 2016-02-12 | CYCLOPHOSPHAMIDE + FILGRASTIM | N | N | 260027612 | BORTEZOMIB |
| 260008296 | 260005587 | null | 92.4 | Curative (C) | 2014-06-02 | 2015-06-02 | BENDAMUSTINE | Y | N | 260027612 | ABVD |
| 260008297 | 260005588 | 1.71 | 77.7 | null | 2013-03-01 | 2013-03-01 | DHAP - R | 2 | null | 260027617 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 260008298 | 260005588 | 1.75 | null | Palliative (P) | 2017-04-22 | 2017-04-25 | EOX | N | N | 260027617 | PACIFICO TRIAL |
| 260008299 | 260005588 | 1.83 | 88 | Curative (C) | 2014-12-21 | 2014-12-25 | BEAM | Y | N | 260027617 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008300 | 260005589 | 1.58 | 68 | Curative (C) | 2018-06-15 | 2018-06-15 | PACIFICO TRIAL | 2 | N | 260027621 | RCEOP |
| 260008301 | 260005589 | 1.69 | 93.6 | Disease modification (D) | 2013-03-17 | 2013-03-18 | ABVD | 2 | N | 260027621 | RITUXIMAB |
| 260008302 | 260005589 | null | 67.5 | Palliative (P) | 2016-10-21 | 2016-11-25 | Pazopanib | 2 | N | 260027621 | GEMCARBO |
| 260008303 | 260005590 | 1.73 | 62.7 | Disease modification (D) | 2017-09-09 | 2017-09-21 | Rituximab | N | N | 260027625 | RITUXIMAB |
| 260008304 | 260011871 | null | 83 | Curative (C) | 2014-04-29 | 2014-05-04 | Rituximab | N | N | 260027626 | RITUXIMAB |
| 260008305 | 260005591 | 1.59 | 60 | Curative (C) | 2017-01-10 | 2017-07-06 | BLEOMYCIN + VINCRISTINE | 02 | N | 260027627 | FEC |
| 260008306 | 260005591 | 1.6 | 96.4 | Curative (C) | 2016-08-07 | 2016-08-10 | Rituximab | 02 | null | 260027627 | RITUXIMAB |
| 260008307 | 260005591 | 1.69 | 70.6 | Disease modification (D) | 2013-12-29 | 2014-01-29 | CAPECITABINE + OXALIPLATIN | N | Y | 260027627 | RITUXIMAB |
| 260008308 | 260005592 | 1.68 | null | Adjuvant (A) | 2015-12-28 | 2015-12-28 | PACIFICO TRIAL | N | N | 260027633 | CHLORAMBUCIL + RITUXIMAB |
| 260008309 | 260005592 | null | 118 | Disease modification (D) | 2017-07-10 | 2017-08-01 | Escalated BEACOPP | N | N | 260027633 | MTX HD + PROCARBAZINE + VINCRISTINE |
| 260008310 | 260005593 | null | null | Palliative (P) | 2013-08-08 | 2013-08-16 | Rituximab | N | N | 260027639 | RITUXIMAB |
| 260008311 | 260005593 | 1.79 | 93.5 | Curative (C) | 2015-07-17 | 2015-07-31 | CHOP - 21 days | 2 | N | 260027639 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 260008312 | 260005594 | 1.73 | 73 | Curative (C) | 2015-10-27 | 2015-11-04 | PACIFICO TRIAL | N | N | 260027641 | PACIFICO TRIAL |
| 260008313 | 260005595 | 1.77 | null | Curative (C) | 2016-07-01 | 2016-07-09 | FCR | 99 | null | 260027643 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008314 | 260005595 | 1.59 | null | Disease modification (D) | 2014-07-16 | 2014-07-16 | Rituximab (Maintenance) | 02 | N | 260027643 | RITUXIMAB |
| 260008315 | 260015503 | 1.74 | 69 | null | 2018-01-12 | 2018-01-14 | GALLIUM TRIAL | 02 | N | 260027646 | RITUXIMAB |
| 260008316 | 260005596 | 1.64 | 97.9 | Palliative (P) | 2013-06-08 | 2013-06-15 | R CODOX-M/ R IVAC | 01 | N | 260027652 | CISPLATIN + RT |
| 260008317 | 260005597 | 1.75 | null | Curative (C) | 2013-09-25 | 2013-10-03 | Rituximab | N | N | 260027653 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260008318 | 260005597 | null | 68.8 | Adjuvant (A) | 2013-10-20 | 2013-10-20 | Rituximab (Maintenance) | 2 | N | 260027653 | PACIFICO TRIAL |